{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T20:03:27Z","timestamp":1789243407256,"version":"build-2803163510"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T00:00:00Z","timestamp":1765152000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T00:00:00Z","timestamp":1765152000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100007366","name":"Fondazione Italiana Sclerosi Multipla","doi-asserted-by":"publisher","award":["FISM2025\/S\/2"],"award-info":[{"award-number":["FISM2025\/S\/2"]}],"id":[{"id":"10.13039\/100007366","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s00415-025-13550-x","type":"journal-article","created":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T14:19:19Z","timestamp":1765203559000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Clinical, functional and cognitive features of late-onset multiple sclerosis"],"prefix":"10.1007","volume":"273","author":[{"given":"Nicol\u00f2","family":"Tedone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Preziosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Meani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damiano","family":"Mistri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Esposito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria A.","family":"Rocca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5485-0479","authenticated-orcid":false,"given":"Massimo","family":"Filippi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,8]]},"reference":[{"issue":"4","key":"13550_CR1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000213967","volume":"105","author":"S Al-Araji","year":"2025","unstructured":"Al-Araji S, Moccia M, Jha A, Zhang L, Eshaghi A, Kanber B, Bianchi A, Yam C, Abdel-Mannan O, Goodkin O, Pontillo G, Hamed W, Mohamud S, Brownlee WJ, Chard DT, Chataway J, Chung KR, De Angelis F, Hammam A, Hacohen Y, Khaleeli Z, Leary SM, Prados F, Swanton J, Thompson AJ, Trip SA, Wilson H, Wright S, Nachev P, Barkhof F, Toosy AT, Ciccarelli O (2025) Effectiveness of disease-modifying therapies in patients with late-onset relapsing-remitting multiple sclerosis. Neurology 105(4):e213967","journal-title":"Neurology"},{"issue":"11","key":"13550_CR2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0165846","volume":"11","author":"R Alroughani","year":"2016","unstructured":"Alroughani R, Akhtar S, Ahmed S, Behbehani R, Al-Hashel J (2016) Is time to reach EDSS 6.0 faster in patients with late-onset versus young-onset multiple sclerosis? PLoS ONE 11(11):e0165846","journal-title":"PLoS ONE"},{"key":"13550_CR3","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1007\/s10072-018-3427-x","volume":"39","author":"M Amato","year":"2018","unstructured":"Amato M, Morra V, Falautano M, Ghezzi A, Goretti B, Patti F, Riccardi A, Mattioli F (2018) Cognitive assessment in multiple sclerosis-an Italian consensus. Neurol Sci 39:1317\u20131324","journal-title":"Neurol Sci"},{"key":"13550_CR4","doi-asserted-by":"publisher","first-page":"Itc81","DOI":"10.7326\/AITC202306200","volume":"176","author":"M Arvanitis","year":"2023","unstructured":"Arvanitis M, Lowenstein CJ (2023) In the clinic dyslipidemia. Ann Intern Med 176:Itc81-U191","journal-title":"Ann Intern Med"},{"key":"13550_CR5","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1016\/S1474-4422(20)30277-5","volume":"19","author":"RHB Benedict","year":"2020","unstructured":"Benedict RHB, Amato MP, DeLuca J, Geurt JJG (2020) Cognitive impairment in multiple sclerosis: clinical management, MRI, and therapeutic avenues. Lancet Neurol 19:860\u2013871","journal-title":"Lancet Neurol"},{"key":"13550_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.829331","volume":"13","author":"MC Buscarinu","year":"2022","unstructured":"Buscarinu MC, Reni\u00e9 R, Morena E, Romano C, Bellucci G, Marrone A, Bigi R, Salvetti M, Ristori G (2022) Late-onset MS: disease course and safety-efficacy of DMTS. Front Neurol 13:829331","journal-title":"Front Neurol"},{"key":"13550_CR7","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1177\/1352458514542363","volume":"21","author":"M Calabrese","year":"2015","unstructured":"Calabrese M, Gajofatto A, Gobbin F, Turri G, Richelli S, Matinella A, Oliboni ES, Benedetti MD, Monaco S (2015) Late-onset multiple sclerosis presenting with cognitive dysfunction and severe cortical\/infratentorial atrophy. Mult Scler J 21:580\u2013589","journal-title":"Mult Scler J"},{"key":"13550_CR8","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1093\/brain\/122.5.871","volume":"122","author":"GR Cutter","year":"1999","unstructured":"Cutter GR, Baier ML, Rudick RA, Cookfair DL, Fischer JS, Petkau J, Syndulko K, Weinshenker BG, Antel JP, Confavreux C, Ellison GW, Lublin F, Miller AE, Rao SM, Reingold S, Thompson A, Willoughby E (1999) Development of a multiple sclerosis functional composite as a clinical trial outcome measure. Brain 122:871\u2013882","journal-title":"Brain"},{"key":"13550_CR9","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1111\/ene.13745","volume":"25","author":"E D'Amico","year":"2018","unstructured":"D\u2019Amico E, Patti F, Zangh\u00ec A, Chisari CG, Lo Fermo S, Zappia M (2018) Late-onset and young-onset relapsing-remitting multiple sclerosis: evidence from a retrospective long-term follow-up study. Eur J Neurol 25:1425\u20131431","journal-title":"Eur J Neurol"},{"key":"13550_CR10","doi-asserted-by":"publisher","first-page":"2753","DOI":"10.2337\/dci22-0034","volume":"45","author":"MJ Davies","year":"2022","unstructured":"Davies MJ, Aroda VR, Collins BS, Gabbay RA, Green J, Maruthur NM, Rosas SE, Del Prato S, Mathieu C, Mingrone G, Rossing P, Tankova T, Tsapas A, Buse JB (2022) Management of hyperglycemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 45:2753\u20132786","journal-title":"Diabetes Care"},{"key":"13550_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-018-0041-4","author":"M Filippi","year":"2018","unstructured":"Filippi M, Bar-Or A, Piehl F, Preziosa P, Solari A, Vukusic S, Rocca MA (2018) Multiple sclerosis. Nat Rev Dis Prim. https:\/\/doi.org\/10.1038\/s41572-018-0041-4","journal-title":"Nat Rev Dis Prim"},{"key":"13550_CR12","doi-asserted-by":"publisher","first-page":"3665","DOI":"10.1093\/brain\/awae251","volume":"147","author":"M Filippi","year":"2024","unstructured":"Filippi M, Preziosa P, Barkhof F, Ciccarelli O, Cossarizza A, De Stefano N, Gasperini C, Geraldes R, Granziera C, Haider L, Lassmann H, Margoni M, Pontillo G, Ropele S, Rovira A, Sastre-Garriga J, Yousry TA, Rocca MA, Grp MS (2024) The ageing central nervous system in multiple sclerosis: the imaging perspective. Brain 147:3665\u20133680","journal-title":"Brain"},{"key":"13550_CR13","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1159\/000479516","volume":"48","author":"F Guillemin","year":"2017","unstructured":"Guillemin F, Baumann C, Epstein J, Kerschen P, Garot T, Mathey G, Debouverie M, Grp L (2017) Older age at multiple sclerosis onset is an independent factor of poor prognosis: a population-based cohort study. Neuroepidemiology 48:179\u2013187","journal-title":"Neuroepidemiology"},{"key":"13550_CR14","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1002\/ana.23974","volume":"74","author":"S Hametner","year":"2013","unstructured":"Hametner S, Wimmer I, Haider L, Pfeifenbring S, Br\u00fcck W, Lassmann H (2013) Iron and neurodegeneration in the multiple sclerosis brain. Ann Neurol 74:848\u2013861","journal-title":"Ann Neurol"},{"key":"13550_CR15","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/S0165-0327(01)00451-7","volume":"72","author":"CJ Hawley","year":"2002","unstructured":"Hawley CJ, Gale TM, Sivakumaran T, Grp HNR (2002) Defining remission by cut off score on the MADRS: selecting the optimal value. J Affect Disord 72:177\u2013184","journal-title":"J Affect Disord"},{"key":"13550_CR16","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.nrl.2020.05.016","volume":"38","author":"AO Ib\u00e1\u00f1ez","year":"2023","unstructured":"Ib\u00e1\u00f1ez AO, Lavi\u00f1neta C, Blanco A (2023) Immunosenescence: the role of age in multiple sclerosis. Neurologia 38:284\u2013290","journal-title":"Neurologia"},{"key":"13550_CR17","first-page":"77","volume":"25","author":"M Kellor","year":"1971","unstructured":"Kellor M, Frost J, Silberberg N, Iversen I, Cummings R (1971) Hand strength and dexterity. Am J Occup Ther 25:77\u201383","journal-title":"Am J Occup Ther"},{"key":"13550_CR18","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1007\/s00415-008-0778-x","volume":"255","author":"B Kis","year":"2008","unstructured":"Kis B, Rumberg B, Berlit P (2008) Clinical characteristics of patients with late-onset multiple sclerosis. J Neurol 255:697\u2013702","journal-title":"J Neurol"},{"key":"13550_CR19","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1080\/14737175.2022.2106854","volume":"22","author":"O Marchesi","year":"2022","unstructured":"Marchesi O, Vizzino C, Filippi M, Rocca MA (2022) Current perspectives on the diagnosis and management of fatigue in multiple sclerosis. Expert Rev Neurother 22:681\u2013693","journal-title":"Expert Rev Neurother"},{"key":"13550_CR20","doi-asserted-by":"publisher","first-page":"2549","DOI":"10.1111\/ene.14471","volume":"27","author":"O Marchesi","year":"2020","unstructured":"Marchesi O, Vizzino C, Meani A, Conti L, Riccitelli GC, Preziosa P, Filippi M, Rocca MA (2020) Fatigue in multiple sclerosis patients with different clinical phenotypes: a clinical and magnetic resonance imaging study. Eur J Neurol 27:2549\u20132560","journal-title":"Eur J Neurol"},{"issue":"1","key":"13550_CR21","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1038\/s41398-023-02555-7","volume":"13","author":"M Margoni","year":"2023","unstructured":"Margoni M, Preziosa P, Rocca MA, Filippi M (2023) Depressive symptoms, anxiety and cognitive impairment: emerging evidence in multiple sclerosis. Transl Psychiatry 13(1):264","journal-title":"Transl Psychiatry"},{"key":"13550_CR22","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1161\/STROKEAHA.119.027230","volume":"51","author":"R Matsuo","year":"2020","unstructured":"Matsuo R, Ago T, Kiyuna F, Sato N, Nakamura K, Kuroda J, Wakisaka Y, Kitazono T, Registry FS (2020) Smoking status and functional outcomes after acute ischemic stroke. Stroke 51:846\u2013852","journal-title":"Stroke"},{"issue":"5","key":"13550_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9051326","volume":"9","author":"O Mirmosayyeb","year":"2020","unstructured":"Mirmosayyeb O, Brand S, Barzegar M, Afshari-Safavi A, Nehzat N, Shaygannejad V, Bahmani DS (2020) Clinical characteristics and disability progression of early- and late-onset multiple sclerosis compared to adult-onset multiple sclerosis. J Clin Med 9(5):1326","journal-title":"J Clin Med"},{"key":"13550_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2021.102816","volume":"50","author":"A Naseri","year":"2021","unstructured":"Naseri A, Nasiri E, Sahraian MA, Daneshvar S, Talebi M (2021) Clinical features of late-onset multiple sclerosis: a systematic review and meta-analysis. Mult Scler Relat Dis 50:102816","journal-title":"Mult Scler Relat Dis"},{"key":"13550_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/jpm14040400","author":"V Nociti","year":"2024","unstructured":"Nociti V, Romozzi M, Mirabella M (2024) Challenges in diagnosis and therapeutic strategies in late-onset multiple sclerosis. J Pers Med. https:\/\/doi.org\/10.3390\/jpm14040400","journal-title":"J Pers Med"},{"key":"13550_CR26","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1212\/WNL.33.12.1537","volume":"33","author":"J Noseworthy","year":"1983","unstructured":"Noseworthy J, Paty D, Wonnacott T, Feasby T, Ebers G (1983) Multiple-sclerosis after age 50. Neurology 33:1537\u20131544","journal-title":"Neurology"},{"key":"13550_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2024.105845","author":"AI Oliveira","year":"2024","unstructured":"Oliveira AI, Monteiro IR, Alferes AR, Santos I, Machado R, Correia I, Mac\u00e1rio C, Nunes CC, Batista S (2024) Cognitive outcomes in late-onset versus adult-onset multiple sclerosis. Mult Scler Relat Disord. https:\/\/doi.org\/10.1016\/j.msard.2024.105845","journal-title":"Mult Scler Relat Disord"},{"key":"13550_CR28","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1177\/13524585211039112","volume":"28","author":"RB Pagnotti","year":"2022","unstructured":"Pagnotti RB, Hua LH, Miller JB (2022) Cognition and disease characteristics in adult onset versus late onset multiple sclerosis. Multiple Scler J 28:933\u2013941","journal-title":"Multiple Scler J"},{"key":"13550_CR29","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1038\/nrneurol.2017.117","volume":"13","author":"IK Penner","year":"2017","unstructured":"Penner IK, Paul F (2017) Fatigue as a symptom or comorbidity of neurological diseases. Nat Rev Neurol 13:662\u2013675","journal-title":"Nat Rev Neurol"},{"key":"13550_CR30","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1046\/j.1532-5415.2001.49038.x","volume":"49","author":"ML Polliack","year":"2001","unstructured":"Polliack ML, Barak Y, Achiron A (2001) Late-onset multiple sclerosis. J Am Geriatr Soc 49:168\u2013171","journal-title":"J Am Geriatr Soc"},{"key":"13550_CR31","volume-title":"A manual for the brief repeatable battery of neuropsychological test in multiple sclerosis","author":"SM Rao","year":"1990","unstructured":"Rao SM, The Cognitive Function Study Group of the National Multiple Sclerosis Society (1990) A manual for the brief repeatable battery of neuropsychological test in multiple sclerosis. Medical College of Wisconsin, Milwaukee"},{"key":"13550_CR32","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1093\/brain\/awv395","volume":"139","author":"KS Rawji","year":"2016","unstructured":"Rawji KS, Mishra MK, Michaels NJ, Rivest S, Stys PK, Yong VW (2016) Immunosenescence of microglia and macrophages: impact on the ageing central nervous system. Brain 139:653\u2013661","journal-title":"Brain"},{"key":"13550_CR33","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/S1474-4422(14)70250-9","volume":"14","author":"MA Rocca","year":"2015","unstructured":"Rocca MA, Amato MP, De Stefano N, Enzinger C, Geurts JJ, Penner IK, Rovira A, Sumowski JF, Valsasina P, Filippi M, Group MS (2015) Clinical and imaging assessment of cognitive dysfunction in multiple sclerosis. Lancet Neurol 14:302\u2013317","journal-title":"Lancet Neurol"},{"key":"13550_CR34","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1177\/1352458516674367","volume":"23","author":"L Ruano","year":"2017","unstructured":"Ruano L, Portaccio E, Goretti B, Niccolai C, Severo M, Patti F, Cilia S, Gallo P, Grossi P, Ghezzi A, Roscio M, Mattioli F, Stampatori C, Trojano M, Viterbo RG, Amato MP (2017) Age and disability drive cognitive impairment in multiple sclerosis across disease subtypes. Mult Scler 23:1258\u20131267","journal-title":"Mult Scler"},{"key":"13550_CR35","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1191\/1352458506ms1258oa","volume":"12","author":"J Sepulcre","year":"2006","unstructured":"Sepulcre J, Vanotti S, Hernandez R, Sandoval G, Caceres F, Garcea O, Villoslada P (2006) Cognitive impairment in patients with multiple sclerosis using the brief repeatable battery-neuropsychology test. Mult Scler 12:187\u2013195","journal-title":"Mult Scler"},{"key":"13550_CR36","doi-asserted-by":"publisher","first-page":"201","DOI":"10.3988\/jcn.2024.0302","volume":"21","author":"R Soares-dos-Reis","year":"2025","unstructured":"Soares-dos-Reis R, Silva P, Ferreira F, Seabra M, Mendon\u00e7a T, Abreu P, Guimaraes J (2025) Multiple sclerosis after the age of 50 years: a comparative analysis of late onset and adult onset. J Clin Neurol 21:201\u2013212","journal-title":"J Clin Neurol"},{"key":"13550_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2025.106399","volume":"97","author":"L Steinegger","year":"2025","unstructured":"Steinegger L, Kana V, Nierobisch N, Elshahabi A, Weller M, Herwerth M, Roth P (2025) Distinct clinical, imaging, and cerebrospinal fluid profiles in people with late-onset multiple sclerosis. Mult Scler Relat Dis 97:106399","journal-title":"Mult Scler Relat Dis"},{"key":"13550_CR38","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1212\/WNL.0b013e318296e98b","volume":"80","author":"JF Sumowski","year":"2013","unstructured":"Sumowski JF, Rocca MA, Leavitt VM, Riccitelli G, Comi G, DeLuca J, Filippi M (2013) Brain reserve and cognitive reserve in multiple sclerosis what you\u2019ve got and how you use it. Neurology 80:2186\u20132193","journal-title":"Neurology"},{"key":"13550_CR39","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1007\/s00415-023-12108-z","volume":"271","author":"N Tedone","year":"2024","unstructured":"Tedone N, Vizzino C, Meani A, Gallo A, Altieri M, D\u2019Ambrosio A, Pantano P, Piervincenzi C, Tommasin S, De Stefano N, Cortese R, Stromillo ML, Rocca MA, Filippi M, network I (2024) The brief repeatable battery of neuropsychological tests (BRB-N) version a: update of Italian normative data from the Italian Neuroimaging Network Initiative (INNI). J Neurol 271:1813\u20131823","journal-title":"J Neurol"},{"key":"13550_CR40","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","volume":"17","author":"AJ Thompson","year":"2018","unstructured":"Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G, Correale J, Fazekas F, Filippi M, Freedman MS, Fujihara K, Galetta SL, Hartung HP, Kappos L, Lublin FD, Marrie RA, Miller AE, Miller DH, Montalban X, Mowry EM, Sorensen PS, Tintor\u00e9 M, Traboulsee AL, Trojano M, Uitdehaag BMJ, Vukusic S, Waubant E, Weinshenker BG, Reingold SC, Cohen JA (2018) Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol 17:162\u2013173","journal-title":"Lancet Neurol"},{"key":"13550_CR41","doi-asserted-by":"publisher","first-page":"j2353","DOI":"10.1136\/bmj.j2353","volume":"357","author":"A Topiwala","year":"2017","unstructured":"Topiwala A, Allan CL, Valkanova V, Zsoldos E, Filippini N, Sexton C, Mahmood A, Fooks P, Singh-Manoux A, Mackay CE, Kivim\u00e4ki M, Ebmeier KP (2017) Moderate alcohol consumption as risk factor for adverse brain outcomes and cognitive decline: longitudinal cohort study. BMJ 357:j2353","journal-title":"BMJ"},{"key":"13550_CR42","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1038\/s41582-025-01115-5","volume":"21","author":"A van der Walt","year":"2025","unstructured":"van der Walt A, Strijbis EMM, Bridge F, Coetzee T, Graves J, Brownlee WJ, Butzkueven H, Marrie RA, Hua LH, Lampe A, Tintore M, Montalban X, Calabresi PA, Barkhof F, Abdelhak A, Amato MP, Amezcua L, Azevedo CJ, Banwell B, Bar-Or A, Bebo BF, Chataway J, Corboy JR, Correale J, Dawson VL, Finlayson M, Fujihara K, Hawton A, Hellwig K, Kappos L, Kos D, Krysko KM, Kuhle J, Frenay CL, Lublin FD, Magyari M, Miller AE, Moccia M, Morrow SA, Mowry EM, Oh J, Pontillo G, Ramanathan S, Rocca MA, Salter A, Salvetti M, Sastre-Garriga J, Smith KE, Sormani MP, Stankoff B, Tremlett H, Weinstock-Guttman B, Wiendl H, Zaratin P, Zhang YN (2025) Advancing multiple sclerosis management in older adults. Nat Rev Neurol 21:432\u2013448","journal-title":"Nat Rev Neurol"},{"key":"13550_CR43","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.991291","author":"B Van Wijmeersch","year":"2022","unstructured":"Van Wijmeersch B, Hartung HP, Vermersch P, Pugliatti M, Pozzilli C, Grigoriadis N, Alkhawajah M, Airas L, Linker R, Oreja-Guevara C (2022) Using personalized prognosis in the treatment of relapsing multiple sclerosis: a practical guide. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2022.991291","journal-title":"Front Immunol"},{"key":"13550_CR44","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2024.1457788","author":"XD Yi","year":"2024","unstructured":"Yi XD, Zhang Y, Du QF, Kang J, Song S, Li T, Jiang YL (2024) Global prevalence of fatigue in patients with multiple sclerosis: a systematic review and meta-analysis. Front Neurol. https:\/\/doi.org\/10.3389\/fneur.2024.1457788","journal-title":"Front Neurol"},{"key":"13550_CR45","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1111\/ene.13786","volume":"26","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, Taylor BV, Simpson S, Blizzard L, van der Mei I (2019) Patient-reported outcomes are worse for progressive-onset multiple sclerosis than relapse-onset multiple sclerosis, particularly early in the disease process. Eur J Neurol 26:155\u2013161","journal-title":"Eur J Neurol"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-025-13550-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-025-13550-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-025-13550-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T12:57:19Z","timestamp":1773665839000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-025-13550-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,8]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["13550"],"URL":"https:\/\/doi.org\/10.1007\/s00415-025-13550-x","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,8]]},"assertion":[{"value":"13 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors do not have any conflicts of interest in relation to this work. Potential conflicts of interest outside the submitted work are the following: N. Tedone, A. Meani, D. Mistri, and F. Esposito have nothing to disclose. P. Preziosa received speaker honoraria from Roche, Biogen, Novartis, Merck, Bristol Myers Squibb, Genzyme, Horizon, and Sanofi; he has received research support from the Italian Ministry of Health and Fondazione Italiana Sclerosi Multipla. M.A. Rocca received consulting fees from Biogen, Bristol Myers Squibb, Eli Lilly, Janssen, Roche; and speaker honoraria from AstraZeneca, Biogen, Bristol Myers Squibb, Bromatech, Celgene, Genzyme, Horizon Therapeutics Italy, Merck Serono SpA, Novartis, Roche, Sanofi, and Teva. She receives research support from the MS Society of Canada, the Italian Ministry of Health, the Italian Ministry of University and Research, and Fondazione Italiana Sclerosi Multipla. She is Associate Editor for Multiple Sclerosis and Related Disorders; and Associate Co-Editor for Europe and Africa for Multiple Sclerosis Journal. M. Filippi is Editor-in-Chief of the Journal of Neurology, Associate Editor of Human Brain Mapping, Neurological Sciences, and Radiology; received compensation for consulting services from Alexion, Almirall, Biogen, Merck, Novartis, Roche, Sanofi; speaking activities from Bayer, Biogen, Celgene, Chiesi Italia SpA, Eli Lilly, Genzyme, Janssen, Merck-Serono, Neopharmed Gentili, Novartis, Novo Nordisk, Roche, Sanofi, Takeda, and TEVA; participation in Advisory Boards for Alexion, Biogen, Bristol-Myers Squibb, Merck, Novartis, Roche, Sanofi, Sanofi-Aventis, Sanofi-Genzyme, and Takeda; and scientific direction of educational events for Biogen, Merck, Roche, Celgene, Bristol-Myers Squibb, Lilly, Novartis, and Sanofi-Genzyme. He receives research support from Biogen Idec, Merck-Serono, Novartis, Roche, the Italian Ministry of Health, the Italian Ministry of University and Research, and Fondazione Italiana Sclerosi Multipla.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"Approval was received from the institutional ethical standards committee on human experimentation of IRCCS Ospedale San Raffaele for any experiments using human subjects (Protocol SENESCENT-MS). Written informed consent was obtained from all subjects prior to study participation according to the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"14"}}